MedPath

Cebix Incorporated

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes

Phase 2
Completed
Conditions
Diabetic Peripheral Neuropathy
Interventions
First Posted Date
2012-09-07
Last Posted Date
2015-01-30
Lead Sponsor
Cebix Incorporated
Target Recruit Count
250
Registration Number
NCT01681290

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Phase 1
Completed
Conditions
Peripheral Diabetic Neuropathy
Type 1 Diabetes
Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2011-02-10
Last Posted Date
2013-03-01
Lead Sponsor
Cebix Incorporated
Target Recruit Count
72
Registration Number
NCT01293461
© Copyright 2025. All Rights Reserved by MedPath